MI
ALNY icon

Motiv8 Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Motiv8 Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3K Buy
+7
New +$3.1K ﹤0.01% 652

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Motiv8 Investments's ALNY Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Alnylam Pharmaceuticals (ALNY) in Q4 2025: 7 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #652 among its holdings.

851 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

  • Motiv8 Investments held 7 shares of Alnylam Pharmaceuticals worth $3K as of Q4 2025.
  • Alnylam Pharmaceuticals was a new Motiv8 Investments position in Q4 2025.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #652 holding.
  • 851 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.